Dr. Friese is being honored for his pioneering work discovering how inflammation is associated with nerve cell death in multiple sclerosis.

The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...

Find Therapeutics secured CA$10 million in funding to continue advancing tasronetide, its treatment to restore damaged myelin ...

Get all latest & breaking news on Multiple Sclerosis. Watch videos, top stories and articles on Multiple Sclerosis at moneycontrol.com.

There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College London (UCL). The finding, if validated, could help doctors provide more ...

January might offer a new year reset, but chronic illness demands us to move forward and bring what we’ve learned, says ...

The Elliot's Neurological Specialties clinic combines medical treatments to slow MS progression with holistic approaches to ...

A team at Johns Hopkins Medicine has focused their work on myelin development using oligodendrocytes to help study conditions like MS.

In experiments with mice, Johns Hopkins Medicine scientists report new evidence that precursors of myelin-producing cells — one of the few brain cell types that continue to be produced in the adult ...

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

MS is currently treated with 'disease-modifying' medicines (e.g. interferon beta, glatiramer acetate, natalizumab, fingolimod, alemtuzumab, teriflunomide, and dimethyl fumarate). These medicines can ...

Maternal diabetes, birthweight may play roles ...